Latest News

 Filter by Provider

Two healthcare stocks that are leading their niches, and two that investors aren't giving enough credit to in the same niches.

As U.S. rare earth production continues to lag China's despite recent trade talks, MP Materials, Energy Fuels and NioCorp Developments each offer investors different ways to gain exposure to domestic critical minerals.

Investors are always following JPMorgan Chase's earnings reports because the bank is a bellwether for the economy.

This overlooked consumer staple is a rock-solid dividend grower built on brands people buy every day.

Agentic AI has opened up some new and exciting opportunities for the tech sector, but there are also some serious concerns.

Retirees will pay the price for this issue with the COLA.

Mirum Pharmaceuticals (NASDAQ:MIRM) said its Phase III EXPAND study of LIVMARLI, or maralixibat, met its primary endpoint and all prespecified secondary endpoints in pediatric patients with cholestatic pruritus associated with ultra-rare cholestatic liver diseases. The placebo-controlled study enro

CXMT plans new DRAM product targeting the AI market before end of 2026.

Realty Income, American Tower, and Public Storage may be positioned to benefit if Treasury yields decline, with analysts offering mixed Buy and Hold ratings on each REIT.

Druckenmiller's second-largest position is Taiwan Semiconductor.

Regulators are looking into reports that Tesla robotaxis speed in school zones.

SK Hynix trades at a fraction of Applied Materials' valuation while posting a 44% net margin, but volatility in the memory market poses a different risk.

Micron Technology stock slid Monday after China's CXMT reported “key progress” on a next-generation DRAM chip.

The nuclear power sector offers options from high-risk industry upstarts like Oklo to reliable dividend stocks like NextEra.

Analysts are expecting a big increase in revenue. But this is the other thing I'm looking for.

What Happened? Shares of mexican fast-food chain Chipotle (NYSE:CMG) fell 4.1% in the morning session after Starbucks denied that it is considering an acquis...

Insiders at H.B. Fuller, FocalTherics, and Cardinal Infrastructure Group are buying shares, signaling potential bottoms backed by analyst price targets, institutional ownership, and growth catalysts.

Anthropic's IPO filing reveals $161 billion in Broadcom commitments, backed by a new $60 billion debt package and AI XPV financing vehicle ahead of its planned mid-November public debut.

The Shiller CAPE ratio deserves respect, but don't let it scare you away from the stock market.

Harmony Biosciences stock took a tumble Monday after its announced the transition of current CEO Jeffrey Dayno at the end of the year.

VT offers broader global exposure with heavy U.S. tech concentration, while VEA focuses on non-U.S. developed markets with lower costs and higher dividend yield.

Investors are focused on Archer Aviation's commercial future, but defense could become the company's nearer-term growth engine.

The Tesla and SpaceX CEO is keeping a lower profile than in 2024.

What Happened? Shares of crude oil tanker operator DHT Holdings (NYSE:DHT) jumped 4.3% in the pre-market session after the company provided an update on its ...

What Happened? Shares of enterprise AI software company C3.ai (NYSE:AI) jumped 4.4% in the pre-market session after Northland upgraded the company to Outperf...

What Happened? Shares of CRM software giant Salesforce (NYSE:CRM) jumped 4.1% in the pre-market session after BofA Securities double-upgraded the stock to Bu...

What Happened? Shares of biotech company Biogen (NASDAQ:BIIB) jumped 3.5% in the pre-market session after JPMorgan upgraded the stock to Overweight from Neut...

What Happened? Shares of supply chain software provider Manhattan Associates (NASDAQ:MANH) jumped 4% in the pre-market session after Morgan Stanley upgraded ...

Palantir has been a big winner due to soaring demand for artificial intelligence, and Ives believes that will continue to be the case next year.

It would be the largest-ever merger in the restaurant sector, though it's still far from certain that it will happen.

While the retail sector trails the broader market this year, Target, Abercrombie & Fitch, Ulta Beauty, and Victoria's Secret have outperformed peers with strong earnings beats ahead of the holiday shopping season.

C.H. Robinson shares fell after its $5.8 billion stock-and-cash deal to acquire RXO, as investors weigh added debt, paused buybacks, and a multiyear wait for promised synergies and EPS accretion.

Salesforce's 18% net margin and fortress balance sheet contrast sharply with ServiceNow's 21% revenue growth and AI-driven momentum, a classic growth-versus-value showdown.

Dividend stocks are getting hit by rising rates, but this trio of high-yielders is still worth buying and holding.

Bristol Myers Squibb scored two Phase 3 wins on Monday in lung disease and cancer. The stock rose, while a key rival plunged.

Amazon stock was flat following reports it is in talks to acquire AI startup Decart for $7 billion.

Both companies burn cash and carry heavy debt, but are chasing huge market potential for their services.

We'll know for sure in just a few days.

First Tracks Biotherapeutics posted "impressive" results for its celiac disease treatment Monday, and the IPO stock surged.

What's bad for bond investors doesn't have to be bad for stocks.

Eli Lilly isn't content with the success of its current GLP-1 drugs; it's on the hunt for even better weight loss solutions.

Hyperscalers like Google are shifting AI data center buildouts to Finland and Norway, drawn by surplus power, stable grids, clear permitting and local support.

Accenture, Curtiss-Wright, and Starbucks all raised their dividends, with Starbucks' hike coming amid reports it explored acquiring Chipotle during its ongoing turnaround.

There's always more to the matter than mere yield (although dividend yields are still important).

This under-the-radar enterprise software stock boasts a Superscore of 83 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

Chewy trades at a fraction of Coupang's valuation multiple, but one faces Amazon's shadow while the other grapples with regulatory headwinds and a major data breach.

SpaceX's recent Starship launch marked a milestone for the company, as it was its first one that successfully went into orbit.